These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11257240)

  • 1. Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease.
    Rasmuson S; Andrew R; Näsman B; Seckl JR; Walker BR; Olsson T
    Biol Psychiatry; 2001 Mar; 49(6):547-52. PubMed ID: 11257240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings.
    Swanwick GR; Kirby M; Bruce I; Buggy F; Coen RF; Coakley D; Lawlor BA
    Am J Psychiatry; 1998 Feb; 155(2):286-9. PubMed ID: 9464214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
    Macut D; Božić Antić I; Nestorov J; Topalović V; Bjekić Macut J; Panidis D; Kastratović Kotlica B; Papadakis E; Matić G; Vojnović Milutinović D
    Hormones (Athens); 2015; 14(1):109-17. PubMed ID: 25402380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease.
    Elgh E; Lindqvist Astot A; Fagerlund M; Eriksson S; Olsson T; Näsman B
    Biol Psychiatry; 2006 Jan; 59(2):155-61. PubMed ID: 16125145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease.
    Masera RG; Prolo P; Sartori ML; Staurenghi A; Griot G; Ravizza L; Dovio A; Chiappelli F; Angeli A
    Psychoneuroendocrinology; 2002 May; 27(4):447-61. PubMed ID: 11911998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender.
    Peskind ER; Raskind MA; Wingerson D; Pascualy M; Thal LJ; Dobie DJ; Wilkinson CW
    Biol Psychiatry; 1996 Jul; 40(1):61-8. PubMed ID: 8780856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptors on mononuclear leukocytes in Alzheimer's disease.
    Rupprecht R; Frölich L; Mergenthaler T; Kornhuber J; Wodarz N; Riederer P; Maurer K
    Psychiatry Res; 1990 Dec; 34(3):237-41. PubMed ID: 1963690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cortisol is associated with cerebral hypometabolism across the Alzheimer's disease spectrum.
    Wirth M; Lange C; Huijbers W;
    Neurobiol Aging; 2019 Dec; 84():80-89. PubMed ID: 31518952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The function of the hypothalamic-pituitary-adrenal axis in Alzheimer's disease. Response to insulin hypoglycaemia.
    O'Brien JT; Schweitzer I; Ames D; Mastwyk M; Colman P
    Br J Psychiatry; 1994 Nov; 165(5):650-7. PubMed ID: 7866680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease.
    Swanwick GR; Coen RF; Walsh JB; Coakley D; Lawlor BA
    Biol Psychiatry; 1996 Jun; 39(11):976-8. PubMed ID: 9162211
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
    O'Brien JT; Ames D; Schweitzer I; Colman P; Desmond P; Tress B
    Br J Psychiatry; 1996 Jun; 168(6):679-87. PubMed ID: 8773809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged hypothalamic-pituitary-adrenal axis activation after acute coronary syndrome in the GENESIS-PRAXY cohort.
    Tang AR; Rabi DM; Lavoie KL; Bacon SL; Pilote L; Kline GA
    Eur J Prev Cardiol; 2018 Jan; 25(1):65-72. PubMed ID: 28969495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A More Holistic Perspective of Alzheimer's Disease: Roles of Gut Microbiome, Adipocytes, HPA Axis, Melatonergic Pathway and Astrocyte Mitochondria in the Emergence of Autoimmunity.
    Anderson G
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):355. PubMed ID: 38179773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease.
    Rasmuson S; Näsman B; Olsson T
    Int Psychogeriatr; 2011 Nov; 23(9):1386-92. PubMed ID: 21729423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders.
    Yehuda R; Boisoneau D; Mason JW; Giller EL
    Biol Psychiatry; 1993 Jul 1-15; 34(1-2):18-25. PubMed ID: 8373936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment of the functional capacity of the hypothalamic-pituitary-adrenal axis by measurement of basal plasma and urinary cortisol in comparison with insulin-induced hypoglycaemia and metyrapone tests.
    de Lange WE; Sluiter WJ
    Neth J Med; 1993 Aug; 43(1-2):64-8. PubMed ID: 8232696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercortisolemia and glucocorticoid receptor-signaling insufficiency in Alzheimer's disease initiation and development.
    Notarianni E
    Curr Alzheimer Res; 2013 Sep; 10(7):714-31. PubMed ID: 23906001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.